0 0 Arran Healthcare Limited 05357412 false 2024-04-01 2025-03-31 2025-03-31 The principal activity of the company is nursing homes and related services Digita Accounts Production Advanced 6.30.9574.0 true false false true 05357412 2024-04-01 2025-03-31 05357412 2025-03-31 05357412 core:RetainedEarningsAccumulatedLosses 2025-03-31 05357412 core:ShareCapital 2025-03-31 05357412 core:CurrentFinancialInstruments 2025-03-31 05357412 core:CurrentFinancialInstruments core:WithinOneYear 2025-03-31 05357412 core:AllSubsidiaries 2025-03-31 05357412 bus:SmallEntities 2024-04-01 2025-03-31 05357412 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 05357412 bus:FilletedAccounts 2024-04-01 2025-03-31 05357412 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 05357412 bus:RegisteredOffice 2024-04-01 2025-03-31 05357412 bus:CompanySecretaryDirector1 2024-04-01 2025-03-31 05357412 bus:Director1 2024-04-01 2025-03-31 05357412 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 05357412 bus:Agent1 2024-04-01 2025-03-31 05357412 core:AllSubsidiaries 2024-04-01 2025-03-31 05357412 core:Subsidiary1 2024-04-01 2025-03-31 05357412 core:Subsidiary1 2024-04-01 2025-03-31 05357412 core:Subsidiary1 1 2024-04-01 2025-03-31 05357412 core:Subsidiary1 countries:EnglandWales 2024-04-01 2025-03-31 05357412 core:Subsidiary2 2024-04-01 2025-03-31 05357412 core:Subsidiary2 1 2024-04-01 2025-03-31 05357412 core:Subsidiary2 countries:England 2024-04-01 2025-03-31 05357412 countries:EnglandWales 2024-04-01 2025-03-31 05357412 core:CostValuation 2024-03-31 05357412 2023-04-01 2024-03-31 05357412 2024-03-31 05357412 core:RetainedEarningsAccumulatedLosses 2024-03-31 05357412 core:ShareCapital 2024-03-31 05357412 core:CurrentFinancialInstruments 2024-03-31 05357412 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 05357412 core:AllSubsidiaries 2024-03-31 05357412 core:Subsidiary1 1 2023-04-01 2024-03-31 05357412 core:Subsidiary2 1 2023-04-01 2024-03-31 xbrli:pure iso4217:GBP

Registration number: 05357412

Arran Healthcare Limited

Annual Report and Unaudited Filleted Financial Statements

for the Year Ended 31 March 2025

 

Arran Healthcare Limited

Contents

Company Information

1

Balance Sheet

2

Notes to the Unaudited Financial Statements

3 to 6

 

Arran Healthcare Limited

Company Information

Directors

Mrs T T Dooraree

DR Dooraree

Company secretary

DR Dooraree

Registered office

78-80 Arran Road
Catford
London
SE6 2NN

Accountants

Manningtons 8 High Street
Heathfield
East Sussex
TN21 8LS

 

Arran Healthcare Limited

(Registration number: 05357412)
Balance Sheet as at 31 March 2025

Note

2025
£

2024
£

Fixed assets

 

Investments

4

106

106

Current assets

 

Debtors

5

301,640

376,946

Cash at bank and in hand

 

713,171

335,128

 

1,014,811

712,074

Creditors: Amounts falling due within one year

6

(128,252)

(77,251)

Net current assets

 

886,559

634,823

Net assets

 

886,665

634,929

Capital and reserves

 

Called up share capital

100

100

Retained earnings

886,565

634,829

Shareholders' funds

 

886,665

634,929

For the financial year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 23 April 2026 and signed on its behalf by:
 

.........................................
DR Dooraree
Company secretary and director

 

Arran Healthcare Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
78-80 Arran Road
Catford
London
SE6 2NN

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

The presentation currency of the financial statements is the Pound Sterling (£).

Business combinations

Business combinations are accounted for using the purchase method. The consideration for each acquisition is measured at the aggregate of the fair values at acquisition date of assets given, liabilities incurred or assumed, and equity instruments issued by the group in exchange for control of the acquired, plus any costs directly attributable to the business combination. When a business combination agreement provides for an adjustment to the cost of the combination contingent on future events, the group includes the estimated amount of that adjustment in the cost of the combination at the acquisition date if the adjustment is probable and can be measured reliably.

Investments

Investments in equity shares which are publicly traded or where the fair value can be measured reliably are initially measured at fair value, with changes in fair value recognised in profit or loss. Investments in equity shares which are not publicly traded and where fair value cannot be measured reliably are measured at cost less impairment.


Interest income on debt securities, where applicable, is recognised in income using the effective interest method. Dividends on equity securities are recognised in income when receivable.

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

 

Arran Healthcare Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised at the transaction price, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised at the transaction price.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 0 (2024 - 0).

4

Investments

2025
£

2024
£

Investments in subsidiaries

106

106

Subsidiaries

£

Cost or valuation

At 1 April 2024

106

Provision

Carrying amount

At 31 March 2025

106

At 31 March 2024

106

 

Arran Healthcare Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

Details of undertakings

Details of the investments (including principal place of business of unincorporated entities) in which the company holds 20% or more of the nominal value of any class of share capital are as follows:

Undertaking

Registered office

Holding

Proportion of voting rights and shares held

2025

2024

Subsidiary undertakings

Aster House Healthcare Ltd

141 Sunderland Road
Forest Hill
London
SE23 2PX

England and Wales

Ordinary

51%

51%

Beechcroft Care Limited

182a Denmark Hill,
London.
SE5 8EE

England

Ordinary

55%

55%

Subsidiary undertakings

Aster House Healthcare Ltd

The principal activity of Aster House Healthcare Ltd is nursing homes and related services..

Beechcroft Care Limited

The principal activity of Beechcroft Care Limited is nursing homes and related services..

5

Debtors

2025
£

2024
£

Other debtors

301,640

376,946

301,640

376,946

 

Arran Healthcare Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

6

Creditors

Creditors: amounts falling due within one year

Note

2025
£

2024
£

Due within one year

 

Amounts owed to group undertakings and undertakings in which the company has a participating interest

7

127,500

76,500

Accruals and deferred income

 

700

700

Other creditors

 

52

51

 

128,252

77,251

7

Related party transactions

Summary of transactions with subsidiaries

Aster House Healthcare Ltd
Beechcrort Care Limited

Summary of transactions with subsidiaries

Expenditure with and payables to related parties

2025

Subsidiary
£

Amounts payable to related party

127,500

2024

Subsidiary
£

Amounts payable to related party

76,500